SCHEMBL87498

SCHEMBL87498

C=C(ONC(=N)C1(NC(=O)OCc2ccccc2)CCC(CO)C1)C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 5/20 0.39
CTSL P07711 4/20 0.39
CTSB P07858 3/20 0.39
RORC P51449 2/20 0.38
TLR2 O60603 2/20 0.36
CTSK P43235 4/20 0.36
CPB1 P15086 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 2/20 0.35
ROCK2 O75116 1/20 0.34
F2 P00734 1/20 0.34
PRSS1 P07477 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13657353 0.86 RORC (0.38) CTSSCTSLCTSBRORCTLR2
SCHEMBL87252 0.82 CTSS (0.43) CTSSCTSLCTSBRORCTLR2
SCHEMBL51559 0.81 CTSS (0.38) CTSSCTSLCTSBRORCTLR2
SCHEMBL13657354 0.80 RORC (0.37) CTSSCTSLCTSBRORCTLR2
SCHEMBL63524 0.75 CTSS (0.37) CTSSCTSLCTSBRORCTLR2
SCHEMBL13691697 0.75 CTSS (0.37) CTSSCTSLCTSBRORCTLR2
SCHEMBL1117846 0.75 CTSS (0.39) CTSSCTSLCTSBRORCTLR2
SCHEMBL1117844 0.75 CTSS (0.39) CTSSCTSLCTSBRORCTLR2
SCHEMBL87300 0.74 CTSS (0.35) CTSSCTSLCTSBRORCTLR2
SCHEMBL13691441 0.73 TSHR (0.46) CTSSCTSLCTSBCPB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129398-B2 HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-06 US disclosed
WO-2009117540-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-24 WO disclosed